In conclusion, the risk of AD and ADRD in patients with hypertension who received angiotensin-II inhibiting antihypertensive medications was higher than in those receiving angiotensin-II stimulating antihypertensive drugs in men and women with colorectal cancer. Here, AGT is linked to hypertensive disorder.